{
    "type": "ETP",
    "ucits": true,
    "replication_method": "synthetic",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "complex_factors": [
        "Leverage",
        "Synthetic replication via FX forwards",
        "Use of derivatives (FX forwards)",
        "Daily reset leverage with compounding effect",
        "Counterparty risk implied by collateralised debt security structure",
        "Complex index tracking (5x leveraged FX forward total return index)"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree Long USD Short EUR 5x Daily product is a UCITS-eligible Exchange Traded Product (ETP) that provides 5 times leveraged exposure to the USD relative to the EUR via a synthetic replication method using FX forward contracts. The product tracks the MSFXSM 5X Long US Dollar/Euro Total Return Index, which is based on FX forwards and includes a daily reset leverage factor, causing compounding effects and deviation from simple 5x index returns over periods longer than one day. The product is described as a Jersey law governed, collateralised debt security, indicating counterparty exposure and credit risk. The KIID explicitly states the use of derivatives (FX forwards) as the underlying exposure mechanism, and the product is fully collateralised but not physically replicating any underlying securities. The risk indicator is at the highest level (7/7), reflecting the high risk and complexity. The product is intended for informed investors with specific knowledge and experience, highlighting the complexity and risk. The presence of leverage, synthetic replication, derivative use, and counterparty risk all drive the classification as complex under MiFID II. The product does not have capital protection, but the complexity arises from the leveraged synthetic exposure and the nature of the underlying index and instruments. The PRIIPs KID and factsheet confirm the use of FX forwards and the daily reset leverage mechanism, reinforcing the synthetic and leveraged nature of the product. No physical replication or direct purchase of underlying securities occurs. The product's complexity is further underscored by the compounding effect of daily leverage resets and the potential for significant tracking error and volatility. Therefore, despite being UCITS eligible, the product is complex due to its synthetic leveraged structure, derivative use, and counterparty risk."
}